# A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer

> **NCT00349492** · PHASE3 · COMPLETED · sponsor: **Clinical Research Center for Solid Tumor, Korea** · enrollment: 372 (estimated)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** IP

## Key facts

- **NCT ID:** NCT00349492
- **Lead sponsor:** Clinical Research Center for Solid Tumor, Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2011-12
- **Final completion:** 2013-10
- **Target enrollment:** 372 (ESTIMATED)
- **Last updated:** 2013-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00349492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00349492, "A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00349492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*